Brendan Classon

Executive VP, R&D

With 20 years of biopharmaceutical industry experience in discovery research and preclinical development of small molecule and biologic therapeutics for autoimmune disease, Brendan has held positions of increasing responsibility in research leadership at Genocea Biosciences, Kiniksa Pharmaceuticals, Novo Nordisk, Sanofi, Regeneron Pharmaceuticals and Bristol-Myers Squibb. Brendan holds a Bachelor of Science with Honors from Monash University and a Doctor of Philosophy in Immunology from The University of Melbourne.